Skip to main content
Signal8

Commodore Capital LP

Commodore Capital LP is an Investment Adviser institutional filer with the SEC under CIK 1831942, reporting 33 portfolio positions, with 20 historical 13F filings on file. Most recent reporting period: 2026-06-30.

A Form 13F reports a manager's US-listed stock and option positions only. It does not include real estate, private funds, bonds, cash or non-US holdings, so a 13F portfolio value is not the firm's total assets under management (AUM).

  • State of incorporation: DE
  • Filing type: 13F-HR
  • Latest reporting period: 2026-06-30
  • Last filed: 2026-08-14

Top 10 portfolio positions

The largest reported holdings in Commodore Capital LP's most recent 13F filing, ranked by reported market value.

  1. RELAY THERAPEUTICS INC (RLAY)
  2. ENLIVEN THERAPEUTICS INC (ELVN)
  3. ALKERMES PLC (ALKS)
  4. COGENT BIOSCIENCES INC (COGT)
  5. AMYLYX PHARMACEUTICALS INC (AMLX)
  6. DEFINIUM THERAPEUTICS INC (DFTX)
  7. SPYRE THERAPEUTICS INC (SYRE)
  8. ALTO NEUROSCIENCE INC (ANRO)
  9. TANGO THERAPEUTICS INC (TNGX)
  10. EYEPOINT INC (EYPT)
/